Cardiovascular Disease Fellowship AY 26
Target Audience
The target audience is Cardiology and Cardiovascular Disease fellows, Physician Assistants, and Cardiology faculty, as well as Morehouse School of Medicine Internal medicine and family medicine residents
Peer reviewer(s)
Anekwe Onwuanyi
has no relevant financial relationships to disclose at this time.
Planner(s)
Tarek Jabi
has no relevant financial relationships to disclose at this time.
Anekwe Onwuanyi
has no relevant financial relationships to disclose at this time.
Speaker(s)
Jalal Ghali
has a financial relationship (Other) with Novartis;.
Elizabeth Ofili
has a financial relationship (Professional Services) with AMGEN;.
has a financial relationship (Professional Services) with NOVARTIS;.
Anekwe Onwuanyi
has no relevant financial relationships to disclose at this time.
Ambarish Pandey, MD, MS
has a financial relationship (Other) with Tricog Health Inc, Lilly USA, Rivus, Cytokinetics, Roche Diagnostics, Axon Therapies, Medtronic, Edward Lifesciences, Science37, Novo Nordisk, Bayer, Medical AI, Astra Zeneca, Baylor Scott and White Research Institute, Boehringer Ingelheim;.
has a financial relationship (Other) with Rhythm Technologies, Tourmaline Bio, Merck, Sarfez Pharmaceuticals, Semler Scientific, Ultromics, Encarda, Boehringer Ingelheim, Tenax Pharma, Alnylam, Abbott, Kieele Health, Anumana, Acorai, Novartis, Antlia Biosciences.;.
Yasir Taha, MD FACC FSCAI
has no relevant financial relationships to disclose at this time.
David Zhuo, MD, FACC, FHFSA
has no relevant financial relationships to disclose at this time.

Facebook
X
LinkedIn
Forward